Amladi AU, Abirami B, Devi SM, Sudarsanam TD, Kandasamy S, Kekre N, Veeraraghavan B, Sahni RD. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res. 2019 Feb;149(2):185-191. doi: 10.4103/ijmr.IJMR_2086_17. PMID: 31219082; PMCID: PMC6563748.

Vijayakumar S, S BA, Kanthan K, Veeraraghavan B. Whole-genome shotgun sequences of seven colistin-resistant Acinetobacter baumannii isolates from bacteraemia. J Glob Antimicrob Resist. 2018 Mar;12:155-156. doi: 10.1016/j.jgar.2018.01.012. Epub 2018 Feb 22. PMID: 29410025.

Shalini Anandan, Lydia Jennifer, Agila Kumari Pragasam, Baby Abirami Shankar, Balaji Veeraraghavan, John Victor Peter and Shoma V Rao. Synergy Testing between Sulbactam and Meropenem/ Colistin in MDR Acinetobacter baumannii-calcoaceticus Complex Isolated from Ventilator Associated Pneumonia. Journal of Infectious Disease and Therapy.2016; 4:299. doi:10.4172/2332-0877.1000299

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Shankar BA, Munusamy E, Anandan S, Veeraraghavan B. Draft genome sequence of blaTEM-1-mediated cephalosporin-resistant Salmonella enterica serovar Typhi from bloodstream infection. J Glob Antimicrob Resist. 2016 Dec;7:11-12. doi: 10.1016/j.jgar.2016.06.003. Epub 2016 Jul 12. PMID: 27530999.

Shankar C, Shankar BA, Manesh A, Veeraraghavan B. KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India. J Med Microbiol. 2018 Jul;67(7):927-930. doi: 10.1099/jmm.0.000767. Epub 2018 May 22. PMID: 29787365.

Veeraraghavan, Balaji & Shankar, Chaitra & Vijayakumar, Saranya & Ragothaman, Harthi & Shankar, Abirami & Lal, Binesh & Manesh, Abi. In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 58. 21002776. 10.1016/j.ijantimicag.2021.106421.6.

Amladi AU, Abirami B, Devi SM, Sudarsanam TD, Kandasamy S, Kekre N, Veeraraghavan B, Sahni RD. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res. 2019 Feb;149(2):185-191. doi: 10.4103/ijmr.IJMR_2086_17. PMID: 31219082; PMCID: PMC6563748.

Vijayakumar S, S BA, Kanthan K, Veeraraghavan B. Whole-genome shotgun sequences of seven colistin-resistant Acinetobacter baumannii isolates from bacteraemia. J Glob Antimicrob Resist. 2018 Mar;12:155-156. doi: 10.1016/j.jgar.2018.01.012. Epub 2018 Feb 22. PMID: 29410025.

Shalini Anandan, Lydia Jennifer, Agila Kumari Pragasam, Baby Abirami Shankar, Balaji Veeraraghavan, John Victor Peter and Shoma V Rao. Synergy Testing between Sulbactam and Meropenem/ Colistin in MDR Acinetobacter baumannii-calcoaceticus Complex Isolated from Ventilator Associated Pneumonia. Journal of Infectious Disease and Therapy.2016; 4:299. doi:10.4172/2332-0877.1000299

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Shankar BA, Munusamy E, Anandan S, Veeraraghavan B. Draft genome sequence of blaTEM-1-mediated cephalosporin-resistant Salmonella enterica serovar Typhi from bloodstream infection. J Glob Antimicrob Resist. 2016 Dec;7:11-12. doi: 10.1016/j.jgar.2016.06.003. Epub 2016 Jul 12. PMID: 27530999.

Shankar C, Shankar BA, Manesh A, Veeraraghavan B. KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India. J Med Microbiol. 2018 Jul;67(7):927-930. doi: 10.1099/jmm.0.000767. Epub 2018 May 22. PMID: 29787365.

Veeraraghavan, Balaji & Shankar, Chaitra & Vijayakumar, Saranya & Ragothaman, Harthi & Shankar, Abirami & Lal, Binesh & Manesh, Abi. In vitro activity of β-lactam-β-lactam enhancer combination, cefepime/zidebactam (WCK 5222, FEP/ZID) against multi-clonal, colistin-resistant Klebsiella pneumoniae. International Journal of Antimicrobial Agents. 58. 21002776. 10.1016/j.ijantimicag.2021.106421.6.

Bakthavatchalam YD, Shankar A, Manokaran Y, Walia K, Veeraraghavan B. Can fosfomycin be an alternative therapy for infections caused by E. coli harbouring dual resistance: NDM and four-amino acid insertion in PBP3? JAC Antimicrob Resist. 2023 Mar 4;5(2):dlad016. doi: 10.1093/jacamr/dlad016. PMID: 36880086; PMCID: PMC9985326.

Chandran S, Manokaran Y, Vijayakumar S, Shankar BA, Bakthavatchalam YD, Dwarakanathan HT, Yesudason BL, Veeraraghavan B. Enhanced bacterial killing with a combination of sulbactam/minocycline against dual carbapenemase-producing Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis. 2023 May;42(5):645-651. doi: 10.1007/s10096-023-04583-z. Epub 2023 Mar 11. PMID: 36905566.

S LJ, Basker MM, Verghese VP, Anandan S, Sethuvel DPM, Abirami SB, Mani T, Balaji V, Prakash JAJ. A Seroepidemiological Survey for Pertussis among Adolescents. Indian J Pediatr. 2021 May;88(5):509. doi: 10.1007/s12098-021-03696-7. Epub 2021 Feb 17. PMID: 33594619.

Jacob JJ, Rachel T, Shankar BA, Gunasekaran K, Iyadurai R, Anandan S, Veeraraghavan B. MLST based serotype prediction for the accurate identification of non typhoidal Salmonella serovars. Mol Biol Rep. 2020 Oct;47(10):7797-7803. doi: 10.1007/s11033-020-05856-y. Epub 2020 Oct 1. PMID: 33001311.

Vijayakumar S, Swetha RG, Bakthavatchalam YD, Vasudevan K, Abirami Shankar B, Kirubananthan A, Walia K, Ramaiah S, Biswas I, Veeraraghavan B, Anbarasu A. Genomic investigation unveils colistin resistance mechanism in carbapenem-resistant Acinetobacter baumannii clinical isolates. Microbiol Spectr. 2024 Feb 6;12(2):e0251123. doi: 10.1128/spectrum.02511-23. Epub 2024 Jan 12. PMID: 38214512; PMCID: PMC10846133.

Karthik M, Panchal NK, T M, Bakthavatchalam YD, Neeravi A, Abirami B, Walia K, Veeraraghavan B. Evolutionary insights into NDM variants: Identification and functional analysis of novel NDM-58 in Pseudomonas aeruginosa. Microb Pathog. 2025 Jul;204:107574. doi: 10.1016/j.micpath.2025.107574. Epub 2025 Apr 12. PMID: 40228751.